Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Interest surrounding glucagon-like peptide 1 agonists (GLP-1), a class of type 2 diabetes drugs that help ...

Getting a 3-month supply You may be able to get a 90-day supply of Rybelsus. If approved by your insurance company, getting a 90-day supply of the drug could reduce your number of trips to the ...

What Is Rybelsus, and Why Does It Matter? Rybelsus (semaglutide) is a once-daily pill used to help lower blood sugar in adults with type 2 diabetes (T2D). It belongs to a group of medicines called GLP ...

Credit: Novo Nordisk. The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral ...

Rybelsus is a prescription drug that’s used to manage type 2 diabetes. Rybelsus comes as tablets that you swallow. You’ll take Rybelsus by mouth once per day, at least 30 minutes before your first ...

The GLP-1 medication Ozempic is now available in pill form for people with type 2 diabetes. The oral tablet is a reformulated version of the current Rybelsus pill but comes in smaller doses. Experts ...

Novo Nordisk A/S is closing in on Eli Lilly in the GLP-1 market despite Ozempic declines. Click for this NVO stock update.

Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic (pre-filled pen) and Rybelsus (oral tablet) for type II diabetes (T2D), and Wegovy ...